News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Roche Alzheimer's Drug Crenezumab Fails Main Goals In Phase 2 Study     7/17/2014
Targacept, Inc. Stops Alzheimer's Drug Trial After It Fails Phase 2b Trial     7/16/2014
Novartis AG To Test Alzheimer's Drugs In Patients Without Symptoms     7/15/2014
German Database Study Hints Takeda Pharmaceutical Co. Ltd.'s Diabetes Drug Cuts Alzheimer's Risk     7/14/2014
Bionomics Limited Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. Worth Up To $526 Million     6/24/2014
Breakthrough: AFFiRiS AG Claims A First In Alzheimer's Disease Therapy     6/6/2014
Neurotez, Inc., GCA Therapeutics Strike $102.5 Million+ Alzheimer's Pact     5/21/2014
AstraZeneca PLC Seeks Partner For Potential $5 Billion Alzheimer's Blockbuster     5/8/2014
PRANA Biotechnology Tanks As Lead Drug Fails Alzheimer's Study     4/1/2014
Anavex Life Sciences Corp. Successfully Closes $10 Million Financing To Initiate Phase 1b/2a Alzheimer's Clinical Trial     3/19/2014
Biogen Idec, Inc. (Massachusetts) Buys Rights To Eisai Company, Ltd. Alzheimer's Drugs, Amount Undisclosed     3/5/2014
Forest Laboratories, Inc. To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR®     2/17/2014
AstraZeneca PLC Takes On Merck & Co., Inc. In Alzheimer's Drug Race     2/7/2014
Doc Admits He Leaked Secret ALZ's Trial Information To "Friend" At SAC     1/21/2014
Investors Bet $22 Million On AC Immune SA, Will Start World's First Anti-Ptau Vaccine Trial For Alzheimer's Disease     1/10/2014

Featured Stories
Fish Oil Supplements May Improve Memory, Slow Cognitive Decline, Rhode Island Hospital Study     7/17/2014
Taking B Vitamins Won’t Prevent Alzheimer's Disease, University of Oxford Study     7/17/2014
10 Proteins In The Blood That Can Predict The Early Alzheimer's Identified, King's College London Reveals     7/10/2014
Alzheimer's Disease To Brain Hyperactivity, Tel Aviv University Study     7/2/2014
Drug Could Stop Alzheimer's By Targeting Clotting Protein, Rockefeller University Study     6/30/2014
Cocoa Extract May Help Treat And Prevent Alzheimer's, Mount Sinai Hospital Study     6/26/2014
Feeding The Brain's Curiosity Holds Off Alzheimer's, Mayo Clinic Study     6/25/2014
Could Brain's "Internal Marijuana" Prevent Alzheimer's? Stanford University Study     6/20/2014
The Science Of How Our Brains Store Recent Memories, Cell By Cell, University of California, San Diego (UCSD) Study     6/17/2014
Depression In The Elderly Linked To Alzheimer's Risk, University of Munich Study     6/10/2014
Light Treatment Improves Sleep, Depression, Agitation In Alzheimer's, Rensselaer Polytechnic Institute Study     6/4/2014
Hope In A Bottle For Alzheimer's and Dementia Patients?     5/23/2014
How A Drug Can Slow Aging, Related Diseases, Oregon State University Study     5/22/2014
Compound Reverses Symptoms Of Alzheimer's Disease In Mice, Saint Louis University Study     5/21/2014
Popular Antidepressant Shows Promise In Slowing Alzheimer's, Washington University School of Medicine Study     5/16/2014

More News
Anavex Life Sciences Corp. (AVXL.OB) Achieves Key Milestone As It Secures Cgmp Manufacturing For Drug Candidate Trial Supplies     7/21/2014
PRANA Biotechnology (PRAN) Alzheimer's Disease Development Program Update     7/18/2014
TauRx Therapeutics Achieves Enrollment Target In The First Of Its Two Phase III Clinical Trials Of LMTX™ In Alzheimer's Disease     7/17/2014
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of Positive Early Results From Prism II Study     7/16/2014
Eli Lilly and Company (LLY) Release: New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis And Management Of Alzheimer's Disease     7/16/2014
Eli Lilly and Company (LLY) Release: New Data Shows Cognitive Impairment Precedes And Predicts Subsequent Functional Impairment In Patients With Mild Alzheimer's Disease     7/15/2014
Amarantus BioSciences, Inc. Announces Positive Clinical Performance And 7-Year Longitudinal Data Poster Presentations For Lympro Test® At AAIC 2014     7/15/2014
Anavex Life Sciences Corp. (AVXL.OB) 3-71 Highly Effective And Disease-Modifying Against All Major Alzheimer's Hallmarks In Preclinical Disease Model     7/14/2014
Eli Lilly and Company (LLY) Release: New Data Shows Combination Therapy Is More Effective Than Monotherapy In Removing Beta-Amyloid Plaques From The Brains Of Mice     7/14/2014
Cytox Release: Role Of mTOR Pathway As A Marker Of Risk In Alzheimer's Disease To Be Presented At AAIC 2014     7/14/2014
Probiodrug AG Presents Development Overview Of PQ912, Probiodrug’s QC-Inhibitor For Alzheimer’s Disease     7/10/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) And Zinfandel Pharmaceuticals Inc. To Present Data At Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches To Alzheimer's Disease Research And Development     7/10/2014
Protea Biosciences, Inc. Announces Alzheimer's Research Collaboration With University of Southampton, U.K.     7/9/2014
Eli Lilly and Company (LLY) To Showcase Data From Its Alzheimer's Disease Portfolio At The Alzheimer's Association International Conference 2014 (AAIC 2014)     7/8/2014
AVANIR Pharmaceuticals (AVNR) Announces Two Data Presentations Related To Pseudobulbar Affect (PBA) At The Alzheimer's Association International Conference (AAIC)     7/1/2014

//-->